Literature DB >> 32909606

The Latent Structure of Negative Symptoms in Individuals With Attenuated Psychosis Syndrome and Early Psychosis: Support for the 5 Consensus Domains.

Wing Chung Chang1,2, Gregory P Strauss3, Anthony O Ahmed4, Sandra C Y Wong1, Joe K N Chan1, Edwin H M Lee1, Sherry K W Chan1,2, Christy L M Hui1, Sydney H James3, Hannah C Chapman3, Eric Y H Chen1,2.   

Abstract

Negative symptoms are prevalent in the prodromal and first-episode phases of psychosis and highly predictive of poor clinical outcomes (eg, liability for conversion and functioning). However, the latent structure of negative symptoms is unclear in the early phases of illness. Determining the latent structure of negative symptoms in early psychosis (EP) is of critical importance for early identification, prevention, and treatment efforts. In the current study, confirmatory factor analysis was used to evaluate latent structure in relation to 4 theoretically derived models: 1. a 1-factor model, 2. a 2-factor model with expression (EXP) and motivation and pleasure (MAP) factors, 3. a 5-factor model with separate factors for the 5 National Institute of Mental Health (NIMH) consensus development conference domains (blunted affect, alogia, anhedonia, avolition, and asociality), and 4. a hierarchical model with 2 second-order factors reflecting EXP and MAP, as well as 5 first-order factors reflecting the 5 consensus domains. Participants included 164 individuals at clinical high risk (CHR) who met the criteria for a prodromal syndrome and 377 EP patients who were rated on the Brief Negative Symptom Scale. Results indicated that the 1- and 2-factor models provided poor fit for the data. The 5-factor and hierarchical models provided excellent fit, with the 5-factor model outperforming the hierarchical model. These findings suggest that similar to the chronic phase of schizophrenia, the latent structure of negative symptom is best conceptualized in relation to the 5 consensus domains in the CHR and EP populations. Implications for early identification, prevention, and treatment are discussed.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  alogia; anhedonia; asociality; avolition; blunted affect

Year:  2021        PMID: 32909606      PMCID: PMC7965067          DOI: 10.1093/schbul/sbaa129

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  52 in total

1.  An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data.

Authors:  David B Flora; Patrick J Curran
Journal:  Psychol Methods       Date:  2004-12

2.  At clinical high risk for psychosis: outcome for nonconverters.

Authors:  Jean Addington; Barbara A Cornblatt; Kristin S Cadenhead; Tyrone D Cannon; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Robert Heinssen
Journal:  Am J Psychiatry       Date:  2011-04-15       Impact factor: 18.112

3.  An overview of Markov chain methods for the study of stage-sequential developmental processes.

Authors:  David Kapland
Journal:  Dev Psychol       Date:  2008-03

4.  Power and sensitivity of alternative fit indices in tests of measurement invariance.

Authors:  Adam W Meade; Emily C Johnson; Phillip W Braddy
Journal:  J Appl Psychol       Date:  2008-05

5.  Negative symptom dimensions differentially impact on functioning in individuals at-risk for psychosis.

Authors:  W C Chang; H C Lee; S I Chan; S Y Chiu; H M Lee; K W Chan; M C Wong; K L Chan; W S Yeung; L W Choy; S Y Chong; M W Siu; T L Lo; W C Yan; M K Ng; L T Poon; P F Pang; W C Lam; Y C Wong; W S Chung; Y M Mo; S Y Lui; L M Hui; E Y H Chen
Journal:  Schizophr Res       Date:  2018-06-21       Impact factor: 4.939

6.  Disorganization/cognitive and negative symptom dimensions in the at-risk mental state predict subsequent transition to psychosis.

Authors:  Arsime Demjaha; Lucia Valmaggia; Daniel Stahl; Majella Byrne; Philip McGuire
Journal:  Schizophr Bull       Date:  2010-08-12       Impact factor: 9.306

7.  A large European, multicenter, multinational validation study of the Brief Negative Symptom Scale.

Authors:  Armida Mucci; Annarita Vignapiano; István Bitter; Stephen F Austin; Camille Delouche; Sonia Dollfus; Andreas Erfurth; W Wolfgang Fleischhacker; Giulia M Giordano; Igor Gladyshev; Birte Glenthøj; Karoline Gütter; Alex Hofer; Jan Hubeňák; Stefan Kaiser; Jan Libiger; Ingrid Melle; Mette Ø Nielsen; Oleg Papsuev; Janusz K Rybakowski; Gabriele Sachs; Alp Üçok; Pawel Wojciak; Silvana Galderisi
Journal:  Eur Neuropsychopharmacol       Date:  2019-06-27       Impact factor: 4.600

8.  Anhedonia in adolescents at ultra-high risk (UHR) of psychosis: findings from a 1-year longitudinal study.

Authors:  Lorenzo Pelizza; Michele Poletti; Silvia Azzali; Federica Paterlini; Sara Garlassi; Ilaria Scazza; Luigi R Chiri; Simona Pupo; Eva Gebhardt; Andrea Raballo
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-05-04       Impact factor: 5.270

9.  Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.

Authors:  Barnaby Nelson; Hok Pan Yuen; Stephen J Wood; Ashleigh Lin; Daniela Spiliotacopoulos; Annie Bruxner; Christina Broussard; Magenta Simmons; Debra L Foley; Warrick J Brewer; Shona M Francey; G Paul Amminger; Andrew Thompson; Patrick D McGorry; Alison R Yung
Journal:  JAMA Psychiatry       Date:  2013-08       Impact factor: 21.596

10.  A multisite investigation of the reliability of the Scale for the Assessment of Negative Symptoms.

Authors:  K T Mueser; S L Sayers; N R Schooler; R M Mance; G L Haas
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

View more
  9 in total

1.  Links of platelet glutamate and glutathione metabolism with attenuated positive and negative symptoms in depressed patients at clinical high risk for psychosis.

Authors:  Irina S Boksha; Maria A Omel'chenko; Olga K Savushkina; Tatyana A Prokhorova; Elena B Tereshkina; Elena A Vorobyeva; Gulnur Sh Burbaeva
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-03-15       Impact factor: 5.270

2.  Clinical, Brain, and Multilevel Clustering in Early Psychosis and Affective Stages.

Authors:  Dominic B Dwyer; Madalina-Octavia Buciuman; Anne Ruef; Joseph Kambeitz; Mark Sen Dong; Caedyn Stinson; Lana Kambeitz-Ilankovic; Franziska Degenhardt; Rachele Sanfelici; Linda A Antonucci; Paris Alexandros Lalousis; Julian Wenzel; Maria Fernanda Urquijo-Castro; David Popovic; Oemer Faruk Oeztuerk; Shalaila S Haas; Johanna Weiske; Daniel Hauke; Susanne Neufang; Christian Schmidt-Kraepelin; Stephan Ruhrmann; Nora Penzel; Theresa Lichtenstein; Marlene Rosen; Katharine Chisholm; Anita Riecher-Rössler; Laura Egloff; André Schmidt; Christina Andreou; Jarmo Hietala; Timo Schirmer; Georg Romer; Chantal Michel; Wulf Rössler; Carlo Maj; Oleg Borisov; Peter M Krawitz; Peter Falkai; Christos Pantelis; Rebekka Lencer; Alessandro Bertolino; Stefan Borgwardt; Markus Noethen; Paolo Brambilla; Frauke Schultze-Lutter; Eva Meisenzahl; Stephen J Wood; Christos Davatzikos; Rachel Upthegrove; Raimo K R Salokangas; Nikolaos Koutsouleris
Journal:  JAMA Psychiatry       Date:  2022-07-01       Impact factor: 25.911

3.  Symptom Structure in Schizophrenia: Implications of Latent Variable Modeling vs Network Analysis.

Authors:  Samuel J Abplanalp; Michael F Green
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

4.  Two Factors, Five Factors, or Both? External Validation Studies of Negative Symptom Dimensions in Schizophrenia.

Authors:  Anthony O Ahmed; Brian Kirkpatrick; Eric Granholm; Laura M Rowland; Peter B Barker; James M Gold; Robert W Buchanan; Tacina Outram; Miguel Bernardo; María Paz García-Portilla; Anna Mane; Emilio Fernandez-Egea; Gregory P Strauss
Journal:  Schizophr Bull       Date:  2022-05-07       Impact factor: 7.348

5.  The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.

Authors:  Gregory P Strauss; Kelsey I Macdonald; Ivan Ruiz; Ian M Raugh; Lisa A Bartolomeo; Sydney H James
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-04-21       Impact factor: 5.270

6.  Alterations in Emotional Diversity Correspond With Increased Severity of Attenuated Positive and Negative Symptoms in the Clinical High-Risk Syndrome.

Authors:  Zachary Anderson; Tina Gupta; William Revelle; Claudia M Haase; Vijay A Mittal
Journal:  Front Psychiatry       Date:  2021-12-23       Impact factor: 4.157

7.  Structure of Negative Symptoms in Schizophrenia: An Unresolved Issue.

Authors:  Manuela Russo; Selman Repisti; Biljana Blazhevska Stoilkovska; Stefan Jerotic; Ivan Ristic; Eldina Mesevic Smajic; Fitim Uka; Aliriza Arenliu; Stojan Bajraktarov; Alma Dzubur Kulenovic; Lidija Injac Stevovic; Stefan Priebe; Nikolina Jovanovic
Journal:  Front Psychiatry       Date:  2021-12-14       Impact factor: 4.157

8.  The Latent Structure of Negative Symptoms in the General Population in Adolescence and Emerging Adulthood.

Authors:  Laura Havers; Alastair Cardno; Daniel Freeman; Angelica Ronald
Journal:  Schizophr Bull Open       Date:  2022-01-12

9.  Secondary Sources of Negative Symptoms in Those Meeting Criteria for a Clinical High-Risk Syndrome.

Authors:  Tina Gupta; Gregory P Strauss; Henry R Cowan; Andrea Pelletier-Baldelli; Lauren M Ellman; Jason Schiffman; Vijay A Mittal
Journal:  Biol Psychiatry Glob Open Sci       Date:  2021-06-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.